Monday, May 23, 2016 4:21:12 PM
http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8018614/further-growth-projected-at-labstyle-innovations
Rodman & Renshaw maintains its Buy rating and $12 price target on LabStyle Innovations Corp
DRIO 1.02%
after the company's better-than-expected first-quarter results.
LabStyle Innovations reported lower-than-projected net loss of $0.33 per share versus the brokerage's estimate of $0.38 per share. Revenues of $568,000 were also slightly above the brokerage's projection of $556,000.
As a result, the brokerage has narrowed its 2016 loss per share estimate to $1.50 from $1.53.
LabStyle would benefit from the uptake of its Dario Smart Meter, according to Rodman & Renshaw. LabStyle launched the Dario Diabetes Management Solution in the United States late in the first quarter of 2016, and has begun online sales in the United States, along with a social media marketing campaign.
Related Link: Quest Diagnostics Reveals Planned Senior Notes Offering For $500M
"In our view, if the company is able to successfully broaden its revenue mix into software and database access sales, our projections from both a top-and bottom-line standpoint could turn out to be extremely conservative," analyst Raghuram Selvaraju wrote in a note.
"Based on sales projected in type 1 diabetes (only 5 percent of the total diabetes population), we believe that LabStyle could generate peak annual Dario product sales (based only on test strips) of roughly $90 million," Selvaraju elaborated.
"We note that the software and database access revenue streams are likely to be significantly higher-margin than sales of the test strips," Selvaraju added.
Read more: http://www.benzinga.com/analyst-ratings/analyst-color/16/05/8018614/further-growth-projected-at-labstyle-innovations#ixzz49VpOWCyk
Recent DRIO News
- Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution • PR Newswire (US) • 04/18/2024 12:30:00 PM
- Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health • PR Newswire (US) • 04/10/2024 12:30:00 PM
- Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health • PR Newswire (US) • 04/02/2024 12:30:00 PM
- DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results • PR Newswire (US) • 03/28/2024 10:30:00 AM
- DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH • PR Newswire (US) • 03/21/2024 12:30:00 PM
- New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications • PR Newswire (US) • 03/12/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:23:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:21:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:20:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:19:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:16:57 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/29/2024 09:03:08 PM
- DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE • PR Newswire (US) • 02/28/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:05:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:16:56 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/21/2024 09:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 12:30:08 PM
- Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions • PR Newswire (US) • 02/21/2024 11:00:00 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:31:35 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/19/2024 09:15:52 PM
- Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support • PR Newswire (US) • 01/11/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 09:10:24 PM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM
Kona Gold Beverages, Inc. Prepares for First Production Run Set to Launch May 17, 2024 • KGKG • Apr 22, 2024 8:30 AM